Featured Research

from universities, journals, and other organizations

Breast Cancer Drug May Protect The Heart, Too

Date:
February 20, 2001
Source:
American Heart Association
Summary:
The breast cancer drug tamoxifen was shown to reduce levels of key inflammatory markers that have been linked to an increased risk of heart disease, researchers report in this month’s Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association.

DALLAS, Feb. 9 – The breast cancer drug tamoxifen was shown to reduce levels of key inflammatory markers that have been linked to an increased risk of heart disease, researchers report in this month’s Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association.

Tamoxifen is in a class of drugs known as selective estrogen receptor modulators (SERMs). The drug has been shown to reduce the incidence of breast cancer in healthy women at high risk of developing that disease.

Similar to postmenopausal hormone therapy, tamoxifen was predicted to reduce cardiovascular risk on the basis of its cholesterol-lowering properties.

In this study, tamoxifen was shown to reduce levels of C-reactive protein (CRP) by 26 percent, and to reduce fibrinogen levels by 22 percent. CRP is a marker for low-grade inflammation. Fibrinogen is a blood coagulation factor and is also a marker of inflammation. High levels of these inflammatory markers have been associated with increased risk for cardiovascular disease in several studies, says Mary Cushman, M.D., M.Sc., lead author of the paper and assistant professor of medicine at the University of Vermont in Burlington.

“Tamoxifen has mixed effects depending on the organ it’s acting on. Therefore, it’s important to determine the drug’s effects on other organs such as the heart and blood vessels, because cardiovascular disease is much more common than breast cancer,” says Cushman on why the research group investigated the cardiovascular effects of tamoxifen. Heart disease is the number one killer of American women.

Previous breast cancer trials have reported 15 percent to 60 percent reductions in cardiac death in women treated with tamoxifen, and researchers linked this effect to the drug’s lipid-lowering properties. Indeed, women on tamoxifen had a 9 percent reduction in total cholesterol levels in this study. However, Cushman reports that the effects on inflammatory markers were larger than on cholesterol.

The study participants were a group of 111 healthy women who were participating in a breast cancer prevention trial called the National Surgical Adjuvant Breast and Bowel Program P-1 trial. The women were age 58 on average and most were postmenopausal. Thirteen of them had two or more risk factors for cardiovascular disease. Every day for six months, 51 women took 20 mg tamoxifen pills, and 60 took a placebo pill. At the end of the study, the research team compared CRP, fibrinogen and cholesterol levels between the tamoxifen and placebo groups.

In the placebo group, fibrinogen and CRP levels did not change significantly from the beginning to the end of the study. In contrast, the tamoxifen group had a 0.64 grams per liter (g/L) decline in fibrinogen levels and a 0.30 mg/L drop in CRP levels.

In a subset of participants who were followed for an additional 18 months, those on tamoxifen still had significantly lower levels of these factors.

Cushman says further research is needed to confirm these findings, and calls for a larger study to investigate the specific effects of tamoxifen on cardiovascular disease risk.

Co-authors include Joseph P. Costantino, Ph.D.; Russell P. Tracy, Ph.D.; Kyunghee Song, Ph.D.; Lenore Buckley, M.D.; John D. Roberts, M.D.; and David N. Krag, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Breast Cancer Drug May Protect The Heart, Too." ScienceDaily. ScienceDaily, 20 February 2001. <www.sciencedaily.com/releases/2001/02/010213070845.htm>.
American Heart Association. (2001, February 20). Breast Cancer Drug May Protect The Heart, Too. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2001/02/010213070845.htm
American Heart Association. "Breast Cancer Drug May Protect The Heart, Too." ScienceDaily. www.sciencedaily.com/releases/2001/02/010213070845.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins